Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 16Unknown 5Recruiting 2Active not recruiting 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Malignant Hepatobiliary Neoplasm 1Gastrointestinal Neoplasms 1Fatigue 1Caregiver Burden 1

Interventions

pembrolizumab 551Specimen Handling 465Carboplatin 441Magnetic Resonance Spectroscopy 430Cyclophosphamide 412Cisplatin 397Radiotherapy 313Gemcitabine 309Bevacizumab 307Paclitaxel 294Biopsy 261Drug Therapy 249Capecitabine 242Oxaliplatin 239fludarabine 237Nivolumab 224venetoclax 219Injections 213Docetaxel 205Fluorouracil 203Dexamethasone 187Radiosurgery 172Rituximab 158Pemetrexed 153Standard of Care 146durvalumab 143Leucovorin 139atezolizumab 138toripalimab 134tislelizumab 134

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Interventional × Acceptance and Commitment Therapy × Clear all
NCT06532877 2026-01-23

Telephone Support in Advanced Gastrointestinal Cancer

Indiana University

Phase NA Recruiting
488 enrolled
Gastrointestinal

Caregiver Burden, Fatigue, Gastrointestinal Neoplasms

NCT07124546 2025-08-15

Acceptance and Commitment Therapy (ACT-HBC) for the Improvement of Cancer Distress in Patients With Hepatobiliary Cancers

Mayo Clinic

Phase NA Recruiting
60 enrolled
Gastrointestinal

Malignant Hepatobiliary Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡